Smith Group Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$690K Sell
3,102
-268
-8% -$62.3K 0.05% 98
2026
Q2
$801K Buy
3,370
+352
+12% +$73.1K 0.03% 117
2026
Q1
$638K Sell
3,018
-131
-4% -$28.2K 0.03% 120
2025
Q4
$647K Buy
3,149
+419
+15% +$78.9K 0.03% 120
2025
Q3
$429K Buy
2,730
+25
+0.9% +$3.86K 0.02% 139
2025
Q2
$454K Sell
2,705
-4,295
-61% -$637K 0.03% 138
2025
Q1
$964K Buy
7,000
+4,340
+163% +$553K 0.07% 86
2024
Q4
$315K Buy
+2,660
New +$311K 0.02% 171
2024
Q3
– Sell
-4,300
Closed -$423K – 141
2024
Q2
$423K Sell
4,300
-5,500
-56% -$560K 0.04% 96
2024
Q1
$1.1M Hold
9,800
– – 0.06% 112
2023
Q4
$988K Buy
+9,800
New +$972K 0.06% 109
2016
Q2
– Sell
-133,100
Closed -$10.9M – 483
2016
Q1
$10.9M Buy
+133,100
New +$10.8M 0.33% 86

Other funds holding CAH

Smith Group Asset Management's CAH Position: Q3 2026 in Review

Smith Group Asset Management reduced its Cardinal Health (CAH) stake by 8% in Q3 2026, selling an estimated $62.3K and leaving 3,102 shares worth $690K. The position accounts for 0.05% of the portfolio, ranked #98.

Smith Group Asset Management first reported a position in CAH in Q1 2016 and has held it in 12 quarters since. The position peaked at $10.9M in Q1 2016. 1,490 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Smith Group Asset Management held 3,102 shares of Cardinal Health worth $690K as of Q3 2026.
  • Smith Group Asset Management sold 268 Cardinal Health shares in Q3 2026, an estimated $62.3K.
  • Cardinal Health made up 0.05% of Smith Group Asset Management's portfolio in Q3 2026, its #98 holding.
  • Smith Group Asset Management first reported a position in Cardinal Health in Q1 2016 and has held it in 12 quarters since.
  • Smith Group Asset Management's Cardinal Health position peaked at $10.9M in Q1 2016.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Smith Group Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.